Search articles in Pharma Appointments
Filter Articles
Open filtersClose filters
Sections
- All (3,721 articles)
- Pharma Events (46 articles)
- For Recruiters (272 articles)
- Careers Events (7 articles)
- Partners (3 articles)
-
News
(3,109 articles)
- Industry Features (118 articles)
- Pharma Appointments (1,382 articles)
- COVID-19 (118 articles)
- Pharmaceuticals (727 articles)
- Biotechnology (155 articles)
- Clinical Research (333 articles)
- Artificial Intelligence (78 articles)
- Medical Devices (64 articles)
- Healthcare (63 articles)
- R & D (103 articles)
- Regulatory Affairs (121 articles)
- HR / Recruitment (9 articles)
- Sales / Commercial (13 articles)
- Manufacturing (26 articles)
- Medical Communications (13 articles)
- HEOR (5 articles)
- Careers Advice (294 articles)
- Company Focus (193 articles)
- Company Career Hubs (1 article)
- Pharma Training (7 articles)
- 25 Years of PharmiWeb (13 articles)
- DE&I (3 articles)
Found 1,382 articles
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
- 3 Dec 2024
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces the appointment of Eckhard Niemeier as its Chief Business Officer (CBO).
Announcement of New CEO Appointment
- 2 Dec 2024
Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
The Bloc Appoints Cristina de los Reyes Muñoz as EU People Director
- 26 Nov 2024
Alessandro Seveso, CEO of The Bloc in Milan, announced the appointment of Cristina de los Reyes Muñoz as EU people director of The Bloc
Lilly announces changes on board of directors
- 22 Nov 2024
Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In addition, the company announced that Karen Walker will transition her role with Lilly, resigning as a member of Lilly's board of directors effective Dec. 31, 2024. In 2025, Ms. Walker will collaborate with Lilly on certain digital commercial activities.
Pfizer Announces New Chief Scientific Officer and President, Research & Development
- 21 Nov 2024
Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025.
-
ABPI welcomes the appointment of new MHRA Chair
- 20 Nov 2024
Anthony Harnden has been appointed the new chair of the Medicine and Healthcare products Regulatory Agency.
Rippon Ubhi appointed Chair of the European Medicines Group
- 15 Nov 2024
Sanofi today announced that Rippon Ubhi has been appointed as the new Chair of the European Medicines Group (EMG). Rippon will continue her role as Country Lead for Sanofi UK & Ireland alongside this new appointment.
pobl. welcomes Lindsey Heer as Partner, Talent Strategy, elevating expertise in Medical Communications and Life Sciences
- 14 Nov 2024
Talent consulting start-up, pobl., is thrilled to announce the addition of Lindsey Heer to its team. Lindsey, an experienced leader in medical communications, with foundations in the pharmaceutical industry, joins pobl. alongside founder Tom Davies
Biotech Entrepreneur Veronica Gambillara Fonck Appointed Chair of MinervaX
- 14 Nov 2024
MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), today announced the appointment of Veronica Gambillara Fonck as its new Chair of the Board of Directors.
Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman
- 14 Nov 2024
Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, announces that Professor David Ebsworth will assume the role of Executive Chairman of Actimed.
Vect-Horus Strengthens Board of Directors with Appointment of Jean-Christophe Dantonel as New Member
- 14 Nov 2024
Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced the appointment of the accomplished scientist and business professional Jean-Christophe Dantonel as a member of its Board of Directors.
Greywolf appoints Darlene Deptula-Hicks as Chief Financial Officer
- 14 Nov 2024
Greywolf Therapeutics, a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system, has appointed Darlene Deptula-Hicks as Chief Financial Officer.
Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel
- 13 Nov 2024
Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan Endell, PhD, as Senior Vice President (SVP), Head of Development, and Alison Hood as General Counsel.
Babraham Research Campus Ltd appoints Dr Louise Jopling as Chief Scientific & Innovation Officer
- 12 Nov 2024
Babraham Research Campus Ltd, which is responsible for the development and management of Babraham Research Campus is delighted to announce the appointment of Dr Louise Jopling to the newly created role of Chief Scientific & Innovation Officer.
Bristol Myers Squibb Creates New Leadership Role, Appointing Karen Costello as General Manager for Ireland
- 7 Nov 2024
Bristol Myers Squibb today announced the appointment of Karen Costello as the new General Manager for its commercial operations in Ireland. In this new role, Karen will lead the delivery of Bristol Myers Squibb’s local commercial strategy, with a focus on evolving how the company engages with customers and stakeholders to drive faster patient access to the medicines they need.
Biosynth Names Matt Gunnison as CEO, Kieran Murphy Appointed as Chairman
- 6 Nov 2024
Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately.
Seaport Therapeutics Names Lauren White as Chief Financial Officer
- 5 Nov 2024
Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the appointment of Lauren White as Chief Financial Officer.
Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development
- 5 Nov 2024
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has appointed Luc Verhees as its new Vice President of Clinical Business Development.
Tessellate BIO Announces Appointment of Lara Boyd as Chief Business Officer
- 5 Nov 2024
Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Dr. Lara Boyd as Chief Business Officer.
Åsa Manelius Named Managing Director of Novavax AB Site
- 5 Nov 2024
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Åsa Manelius, will join the Company in February 2025 as Managing Director of the Novavax AB site in Uppsala, Sweden, the primary manufacturing site for Matrix-M.
